Hikari-gaoka 1
Fukushima, 960-1295
Japan
hormone receptor positive breast cancer, extended adjuvant endocrine therapy, aromatase inhibitor, late recurrence
breast cancer, CYP2D6, endoxifen, genotype-guided dosing, tamoxifen